INSP Inspire Medical Systems Inc

$92.60

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Inspire Medical Systems is poised to capture investor attention as it approaches its upcoming earnings release, with a market cap of approximately $2.39 billion underscoring its significant presence in the medical device sector. Despite the EPS estimate and whisper number both standing at $0.00, indicating a neutral earnings expectation, the focus will likely shift to the company's revenue performance, projected at $220.40 million. This revenue estimate will be a critical indicator of Inspire's ability to maintain its growth trajectory, especially in the absence of recent news or strategic developments. Investors will be keen to see if the company can meet or exceed this revenue target, as it would signal continued demand for its innovative sleep apnea solutions. As the earnings date approaches, market sentiment will likely hinge on Inspire's capacity to leverage its market position and deliver on revenue expectations, providing a clearer picture of its financial health and future prospects.

Updated On 12/31/2025

About Inspire Medical Systems Inc

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. The company is headquartered in Golden Valley, Minnesota.

Website: https://www.inspiresleep.com

Sector
LIFE SCIENCES
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1609550
Address
5500 WAYZATA BLVD, SUITE 1600, GOLDEN VALLEY, MN, US
Valuation
Market Cap
$4.47B
P/E Ratio
85.35
PEG Ratio
nan
Price to Book
6.48
Performance
EPS
$1.76
Dividend Yield
Profit Margin
6.67%
ROE
8.48%
Technicals
50D MA
$168.18
200D MA
$180.98
52W High
$257.40
52W Low
$123.00
Fundamentals
Shares Outstanding
30M
Target Price
$226.07
Beta
1.39

INSP EPS Estimates vs Actual

Estimated
Actual

INSP News & Sentiment

Dec 31, 2025 • Business Wire BEARISH
INSP INVESTORS: Contact Kirby McInerney LLP About Securities Class Action Lawsuit On Behalf of Inspire Medical Systems, Inc.
Kirby McInerney LLP reminds investors of Inspire Medical Systems, Inc. (NYSE:INSP) about the January 5, 2026 deadline to seek lead plaintiff status in a class action lawsuit. The lawsuit alleges that Inspire Medical Systems made false or misleading statements regarding the poor demand and problematic launch of its Inspire V medical device, leading to a significant stock price drop. Investors who acquired Inspire securities between August 6, 2024, and August 4, 2025, and suffered losses are encouraged to contact the firm.
Dec 30, 2025 • GlobeNewswire BEARISH
Deadline Alert: Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Glancy Prongay & Murray LLP is alerting shareholders of Inspire Medical Systems, Inc. (INSP) to a securities fraud lawsuit deadline on January 5, 2026. The lawsuit claims that Inspire made misleading statements between August 6, 2024, and August 4, 2025, concerning issues with its new Inspire V sleep apnea device launch, leading to a significant stock price drop. Investors who suffered losses are encouraged to contact the firm to inquire about potentially recovering their losses.
Dec 30, 2025 • ACCESS Newswire BEARISH
Inspire Medical Systems, Inc. (INSP) Shareholders Get Answers in Latest SueWallSt Podcast
Levi & Korsinsky, LLP has released a podcast addressing a class action securities lawsuit filed on behalf of Inspire Medical Systems, Inc. (NYSE:INSP) investors. The lawsuit alleges securities fraud between August 6, 2024, and August 4, 2025, claiming the company made false statements and concealed issues regarding the unsuccessful launch of its new product, Inspire V. The firm encourages shareholders who have suffered losses to contact them for more information.
Dec 30, 2025 • KRON4 BEARISH
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm is reminding investors of a class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP) for alleged securities fraud violations between August 6, 2024, and August 4, 2025. The lawsuit claims that Inspire made misleading statements about the launch of its Inspire V device, which reportedly had weak demand and was poorly managed. Investors who suffered losses are encouraged to contact the firm by January 5, 2026, to participate in the lawsuit.
Dec 29, 2025 • GlobeNewswire BEARISH
Bronstein, Gewirtz & Grossman LLC Urges Inspire Medical Systems, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP) and its officers. The lawsuit seeks to recover damages for investors who purchased Inspire securities between August 6, 2024, and August 4, 2025, alleging the company made materially false and misleading statements about the demand and launch readiness of Inspire V. Investors have until January 5, 2026, to request to be appointed as lead plaintiff.
Dec 29, 2025 • KRON4 BEARISH
Inspire Medical Systems, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INSP
DJS Law Group is reminding investors of a class-action lawsuit against Inspire Medical Systems, Inc. (INSP) for alleged securities law violations. The lawsuit claims Inspire made false and misleading statements regarding the launch of its Inspire V therapy system, which was met with weak demand despite company claims of high market demand. Shareholders who purchased INSP shares between August 6, 2024, and August 4, 2025, are encouraged to contact DJS Law Group to discuss their rights and potential lead plaintiff appointments, with a deadline of January 5, 2026.
Sentiment Snapshot

Average Sentiment Score:

-0.605
50 articles with scored sentiment

Overall Sentiment:

Bearish

INSP Reported Earnings

Aug 04, 2025
Jun 30, 2025 (Post market)
0.25 Surprise
  • Reported EPS: $0.45
  • Estimate: $0.20
  • Whisper:
  • Surprise %: 125.0%
May 05, 2025
Mar 31, 2025 (Post market)
0.33 Surprise
  • Reported EPS: $0.10
  • Estimate: $-0.23
  • Whisper:
  • Surprise %: 143.5%
Feb 10, 2025
Dec 31, 2024 (Post market)
0.43 Surprise
  • Reported EPS: $1.15
  • Estimate: $0.72
  • Whisper:
  • Surprise %: 59.7%
Nov 04, 2024
Sep 30, 2024 (Post market)
0.54 Surprise
  • Reported EPS: $0.60
  • Estimate: $0.06
  • Whisper:
  • Surprise %: 900.0%
Aug 06, 2024
Jun 30, 2024 (Post market)
0.46 Surprise
  • Reported EPS: $0.32
  • Estimate: $-0.14
  • Whisper:
  • Surprise %: 328.6%
May 07, 2024
Mar 31, 2024 (Post market)
0.31 Surprise
  • Reported EPS: $-0.34
  • Estimate: $-0.65
  • Whisper:
  • Surprise %: 47.7%
Feb 06, 2024
Dec 31, 2023 (Post market)
0.58 Surprise
  • Reported EPS: $0.49
  • Estimate: $-0.09
  • Whisper:
  • Surprise %: 644.4%
Nov 07, 2023
Sep 30, 2023 (Post market)
0.29 Surprise
  • Reported EPS: $-0.29
  • Estimate: $-0.58
  • Whisper:
  • Surprise %: 50.0%
Aug 01, 2023
Jun 30, 2023 (Post market)
0.16 Surprise
  • Reported EPS: $-0.41
  • Estimate: $-0.57
  • Whisper:
  • Surprise %: 28.1%

Financials